Isatis Tinctoria Root

Dosage for Isatis Tinctoria Root varies significantly based on the preparation and the clinical objective.

Diagnostic Use (Allergy Testing)

For skin prick testing, a single drop of the non-standardized extract (typically at a concentration of 1:10 or 1:20 w/v) is applied to the volar surface of the forearm. For patch testing, a 1% to 5% concentration in petrolatum is typically applied to the back for 48 to 72 hours.

Oral Supplemental Use (Traditional Context)

When used in traditional medicine, the standard dose of the dried root for decoction is 10 to 15 grams daily. If using standardized granules, the typical dose is 3 to 6 grams taken two to three times per day, dissolved in warm water.

Copper Absorption Inhibition

There is no standardized FDA-approved dose for copper inhibition. In clinical research settings, doses are individualized based on the patient's baseline copper levels and the specific protocol being followed. Patients must be under strict medical supervision when using this substance for mineral modulation.

Isatis Tinctoria Root is not broadly approved for pediatric use in a diagnostic or therapeutic capacity in the United States. In traditional settings, pediatric doses are often reduced by half or adjusted based on body weight (e.g., 0.5 to 1 gram per year of age). However, due to the risk of specific side effects and the lack of rigorous safety data in children, it should only be used under the direct supervision of a pediatrician or qualified specialist.

Renal Impairment

Patients with significant renal impairment (reduced kidney function) should use Isatis Tinctoria Root with caution. While specific dose-adjustment guidelines are not established, reduced clearance of alkaloids may lead to accumulation. Monitoring of kidney function (Creatinine/GFR) is recommended for long-term use.

Hepatic Impairment

Because the liver is the primary site of metabolism for Isatis-derived alkaloids, patients with hepatic impairment (liver disease) may require lower doses. Clinicians should monitor liver enzymes (ALT/AST) closely.

Elderly Patients

Elderly patients often have reduced physiological reserve and may be taking multiple medications. Dosing should start at the lower end of the spectrum, with careful monitoring for gastrointestinal upset and potential drug interactions.

• Diagnostic Testing: This must be performed by a healthcare professional in a clinical setting equipped to handle anaphylaxis (severe allergic reaction).
• Oral Granules: Dissolve the prescribed amount of granules in 4 to 6 ounces of warm water. Stir well and drink immediately. It is generally recommended to take this after meals to minimize stomach upset.
• Decoctions: If using the raw root, boil the root in water for 20-30 minutes, strain, and drink the liquid as directed by a healthcare provider.
• Storage: Store all forms in a cool, dry place away from direct sunlight. Keep out of reach of children and pets.

If you miss a dose of an oral preparation, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not double the dose to catch up, as this increases the risk of gastrointestinal toxicity.

Signs of overdose with Isatis Tinctoria Root may include severe nausea, vomiting, diarrhea, abdominal pain, and potentially dizziness or lethargy. In cases of significant overconsumption, there is a theoretical risk of excessive copper depletion, leading to symptoms like neutropenia (low white blood cell count) or anemia.

In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on hydration and symptom management.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

When used for diagnostic skin testing, the most common side effect is a localized reaction at the site of application. This typically includes:

• Pruritus (Itching): A localized itchy sensation that usually subsides within a few hours.
• Erythema (Redness): Reddening of the skin around the test site.
• Wheal Formation: A raised, pale, or reddish bump (similar to a mosquito bite) that is a normal part of a positive allergy test.

When taken orally, common side effects include:

• Gastrointestinal Distress: Mild nausea, bloating, or 'heaviness' in the stomach.
• Loose Stools: A mild laxative effect is frequently reported with high doses of the root extract.

• Dizziness: Some patients report a mild feeling of lightheadedness shortly after oral administration.
• Anorexia (Loss of Appetite): Temporary reduction in desire to eat.
• Contact Dermatitis: When used topically, some individuals may develop a localized rash or skin irritation that persists for several days.

• Hepatotoxicity (Liver Injury): Rare reports of elevated liver enzymes have occurred with prolonged, high-dose use of Isatis extracts.
• Hematologic Changes: Rare instances of leukopenia (reduced white blood cells) have been noted in clinical literature, though a direct causal link is not always established.
• Hypersensitivity Pneumonitis: Inhalation of the powdered root or dust in occupational settings has rarely led to lung inflammation.

> Warning: Stop taking Isatis Tinctoria Root and call your doctor immediately if you experience any of these.

• Anaphylaxis: Signs include difficulty breathing, swelling of the face, lips, or tongue, severe hives, and a rapid drop in blood pressure. This is a medical emergency.
• Severe Gastrointestinal Bleeding: While extremely rare, any signs of black, tarry stools or vomiting blood require immediate evaluation.
• Jaundice: Yellowing of the eyes or skin, which may indicate acute liver distress.
• Significant Neutropenia: Signs include unexplained fever, chills, or frequent infections, which may result from excessive copper inhibition or direct bone marrow suppression.

Prolonged use of Isatis Tinctoria Root as a copper absorption inhibitor can lead to Copper Deficiency. Copper is essential for the function of numerous enzymes, including cytochrome c oxidase (energy production) and superoxide dismutase (antioxidant defense). Long-term deficiency can result in:

• Microcytic Anemia: Anemia characterized by small red blood cells that does not respond to iron supplementation.
• Neurological Symptoms: Including ataxia (loss of coordination) and peripheral neuropathy (numbness/tingling in hands and feet), similar to Subacute Combined Degeneration of the spinal cord.
• Osteoporosis: Weakening of the bones over time.

As of 2026, there are no FDA black box warnings specifically for Isatis Tinctoria Root. However, clinicians are advised that non-standardized allergenic extracts carry a general risk of systemic allergic reactions, including anaphylaxis, during diagnostic procedures. Testing should only occur in facilities equipped with epinephrine and resuscitation equipment.

Report any unusual symptoms to your healthcare provider.

Isatis Tinctoria Root must be used with caution, particularly in individuals with a history of severe allergies or those with pre-existing metabolic disorders. It is not a substitute for conventional medical treatment for acute infections or chronic diseases. Patients should be aware that because many preparations are non-standardized, the concentration of active alkaloids can vary significantly between different brands or batches.

No FDA black box warnings for Isatis Tinctoria Root. However, it is important to note that all allergenic extracts are associated with a risk of severe systemic reactions. According to the General Requirements for Allergenic Products (21 CFR Part 680), these products must be administered by trained professionals.

• Allergic Reactions / Anaphylaxis Risk: Patients with a known hypersensitivity to plants in the Brassicaceae family (mustard, broccoli, cabbage) may be at an increased risk of cross-reactivity. During diagnostic testing, patients must be monitored for at least 30 minutes post-procedure.
• Hepatotoxicity: There is a potential risk for liver injury with high doses. Patients with pre-existing liver disease (e.g., Hepatitis B/C, Cirrhosis) should avoid use unless directed by a specialist.
• Nephrotoxicity: While less common, the presence of certain glucosinolates may stress renal function in patients with stage 4 or 5 chronic kidney disease.
• Copper Homeostasis: Because this substance is a Copper Absorption Inhibitor [EPC], it should not be used by individuals who already have low copper levels or those with Menkes disease (a genetic disorder of copper transport).

For patients using Isatis Tinctoria Root long-term or at high doses, the following monitoring is recommended:

• Complete Blood Count (CBC): To monitor for anemia or neutropenia related to copper inhibition.
• Liver Function Tests (LFTs): Including ALT, AST, and Bilirubin every 3-6 months.
• Serum Copper and Ceruloplasmin: To ensure copper levels remain within the physiological range (typically 70-150 µg/dL for serum copper).

Isatis Tinctoria Root generally does not cause sedation. However, if a patient experiences dizziness or lightheadedness as a side effect, they should refrain from driving or operating heavy machinery until the symptoms resolve.

Alcohol should be avoided or minimized when taking Isatis Tinctoria Root. Alcohol can exacerbate the risk of gastrointestinal irritation and may increase the metabolic load on the liver, potentially heightening the risk of hepatotoxicity.

There is no known withdrawal syndrome associated with the discontinuation of Isatis Tinctoria Root. However, if used for copper modulation, stopping the substance may lead to a rapid return to baseline copper absorption levels. Patients should consult their doctor before stopping any prescribed regimen.

> Important: Discuss all your medical conditions with your healthcare provider before starting Isatis Tinctoria Root.

• Zinc Supplements (High Dose): Both zinc and Isatis Tinctoria Root act as copper absorption inhibitors. Using them together can lead to profound copper deficiency and subsequent hematologic or neurologic damage. This combination must be avoided unless specifically managed by a specialist in metabolic medicine.
• Specific Chemotherapeutic Agents: Due to the indirubin content, which inhibits cyclin-dependent kinases, there is a risk of antagonistic (opposing) effects with certain cell-cycle-specific chemotherapy drugs.

• Warfarin and Anticoagulants: Isatis Tinctoria Root contains vitamin K-like compounds and other phytochemicals that may theoretically interfere with blood clotting or the efficacy of Warfarin. Monitoring of the International Normalized Ratio (INR) is essential.
• Hepatotoxic Drugs: Combining Isatis with other drugs known to cause liver stress (e.g., high-dose Acetaminophen, Methotrexate, Amiodarone) increases the risk of drug-induced liver injury (DILI).

• CYP3A4 Substrates: Isatis constituents may weakly inhibit the CYP3A4 enzyme, potentially increasing the blood levels of drugs like Simvastatin, Cyclosporine, or certain Calcium Channel Blockers. Dose adjustments may be necessary.
• Antidiabetic Medications: Preliminary studies suggest Isatis may have mild glucose-lowering effects. When combined with Insulin or Metformin, there is a slight increase in the risk of hypoglycemia (low blood sugar).

• High-Fiber Diets: Excessive dietary fiber may further bind the active alkaloids in Isatis, potentially reducing its efficacy as a copper inhibitor.
• Cruciferous Vegetables: Consuming large amounts of broccoli, kale, or cabbage while taking Isatis may lead to an additive effect on the thyroid gland due to the presence of goitrin (a substance that can interfere with thyroid hormone production).

• St. John's Wort: May induce the metabolism of Isatis alkaloids, reducing their concentration and effectiveness.
• Phytic Acid / Phytates: Found in grains and legumes, these can further inhibit mineral absorption, complicating the management of copper levels.

• Serum Copper/Ceruloplasmin: Isatis will directly lower these values; this is a pharmacodynamic effect rather than a laboratory interference.
• Urine Glucose: Some botanical constituents can cause false-positive or false-negative results in certain older urine dipstick tests.

For each major interaction, the mechanism typically involves either competitive inhibition at the site of intestinal absorption (mineral interactions) or modulation of the hepatic cytochrome P450 system (drug interactions). The clinical consequence is usually either an increased risk of toxicity from the co-administered drug or a deficiency in essential trace minerals.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Isatis Tinctoria Root must NEVER be used in the following circumstances:

• Known Hypersensitivity: Any patient with a documented severe allergy to Isatis tinctoria or its constituents (e.g., indirubin, tryptanthrin) must avoid all forms of the drug. The mechanism is a Type I hypersensitivity reaction which could lead to fatal anaphylaxis.
• Wilson's Disease (Untreated): While it inhibits copper absorption, Isatis is not an approved or sufficiently potent treatment for Wilson's disease (a genetic disorder of copper accumulation). Relying on it instead of approved chelators like Penicillamine can lead to irreversible liver and brain damage.
• Severe Hepatic Failure: Due to the liver's role in metabolizing the root's alkaloids, patients with end-stage liver disease cannot safely process the substance, leading to potential systemic toxicity.

Conditions requiring careful risk-benefit analysis include:

• G6PD Deficiency: There is a theoretical risk that certain oxidative compounds in the root could trigger hemolysis (breakdown of red blood cells) in susceptible individuals.
• Thyroid Disorders: Because Isatis contains goitrin, which can inhibit iodine uptake by the thyroid, patients with hypothyroidism or goiter should use it with extreme caution and regular TSH monitoring.
• Pregnancy and Lactation: Due to the lack of safety data and the potential for alkaloids to affect fetal development, use is generally discouraged.

Patients allergic to other members of the Brassicaceae family may exhibit cross-sensitivity to Isatis Tinctoria Root. This includes:

• Mustard seeds and mustard greens
• Broccoli and Cauliflower
• Brussels sprouts
• Rapeseed (Canola)
• Horseradish

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Isatis Tinctoria Root.

Isatis Tinctoria Root is generally classified as Category C (or the equivalent in 2026 guidelines). There are no adequate and well-controlled studies in pregnant women. Animal studies on certain alkaloids like indirubin have suggested potential embryotoxicity at high doses. Furthermore, the inhibition of copper absorption is a significant concern during pregnancy, as copper is vital for fetal heart and skeletal development. Use during pregnancy is not recommended unless the potential benefit clearly outweighs the risk to the fetus.

It is unknown whether the alkaloids or other constituents of Isatis Tinctoria Root are excreted in human milk. Because many of the compounds are low molecular weight and lipophilic, passage into breast milk is likely. Due to the potential for adverse effects on the nursing infant's developing immune system and mineral balance, a decision should be made whether to discontinue nursing or discontinue the drug.

Safety and effectiveness in pediatric patients have not been established by the FDA. In traditional medicine, it is used in children, but reports of gastrointestinal distress and the risk of undiagnosed allergies make it a high-risk intervention. It is specifically NOT approved for use in infants under 12 months of age due to the immaturity of their metabolic pathways.

Clinical studies have not included sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, geriatric patients are more likely to have decreased renal and hepatic function. There is also an increased risk of polypharmacy (taking multiple drugs) in the elderly, which heightens the risk of drug-drug interactions. Dosing should be cautious, typically starting at the low end of the range.

In patients with a GFR (Glomerular Filtration Rate) less than 30 mL/min/1.73m², the clearance of Isatis metabolites is significantly reduced. No specific dose-adjustment formulas exist, but a 50% dose reduction is often suggested in clinical practice for oral forms, along with frequent monitoring of serum electrolytes and kidney function.

For patients with Child-Pugh Class B or C hepatic impairment, Isatis Tinctoria Root should be avoided. In Class A (mild) impairment, the drug may be used with caution, but therapy should be discontinued if liver enzymes rise to more than three times the upper limit of normal (3x ULN).

> Important: Special populations require individualized medical assessment.

Isatis Tinctoria Root acts through several distinct molecular pathways. As a Standardized Chemical Allergen [EPC], its proteins serve as ligands for IgE on mast cells. As a Copper Absorption Inhibitor [EPC], it contains sulfur-rich glucosinolates and specific organic acids that chelate dietary copper (Cu2+) in the acidic environment of the stomach and the slightly alkaline environment of the duodenum. This chelation creates a large, insoluble complex that cannot be recognized by the CTR1 (Copper Transporter 1) protein on the apical membrane of enterocytes.

Furthermore, the alkaloid Indirubin acts as a potent inhibitor of Cyclin-Dependent Kinases (CDKs 1, 2, and 5). By competing for the ATP-binding site of these enzymes, it halts the cell cycle in the G2/M phase. Tryptanthrin acts by downregulating the expression of inducible Nitric Oxide Synthase (iNOS) and COX-2, thereby reducing the production of nitric oxide and prostaglandins, respectively.

The onset of copper inhibition is rapid, occurring within 30 to 60 minutes of oral ingestion (coinciding with gastric emptying). The duration of effect for a single dose is approximately 6 to 8 hours. Regarding its anti-inflammatory effects, the peak pharmacodynamic action usually lags behind peak plasma concentrations, often taking 2 to 4 days of consistent dosing to manifest.

| Parameter | Value |

|---|---|

| Bioavailability | 15% - 25% (Indirubin) |

| Protein Binding | 75% - 85% (primarily to Albumin) |

| Half-life | 4.5 hours (Epigoitrin) |

| Tmax | 1.5 - 2.5 hours |

| Metabolism | Hepatic (CYP1A2, CYP3A4 minor) |

| Excretion | Renal 60%, Fecal 40% |

• Molecular Formula: C16H10N2O2 (Indirubin)
• Molecular Weight: 262.26 g/mol (Indirubin)
• Solubility: Poorly soluble in water; soluble in DMSO and hot ethanol.
• Structure: A bis-indole alkaloid consisting of two indole rings linked by a double bond.

Isatis Tinctoria Root is classified as a Non-Standardized Fungal Allergenic Extract [EPC] and a Copper Absorption Inhibitor [EPC]. It is related to other botanical allergenic extracts like Ambrosia artemisiifolia (Ragweed) and other mineral modulators like Zinc Acetate.